Evidence map›Paper›PMID 40103341›Full record

ArticleThe European journal of neuroscience2025

Electroencephalography (EEG) and the Quest for an Inclusive and Global Neuroscience.

Faisal Mushtaq, Agustín Ibáñez

Abstract read
In one paragraph

Article in The European journal of neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Faisal MushtaqSchool of Psychology, University of Leeds, Leeds, UK.
Agustín IbáñezLatin American Brain Health Institute, Universidad Adolfo Ibañez, Santiago, Chile.ORCID 0000-0001-6758-5101

Funding

An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populationsR01AG075775 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARIA LUISA GORNO TEMPINI, Adolfo Martin Garcia · 2023 to 2026
$7.2M
US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative ResearchR01AG057234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Claudia Duran-Aniotz, Agustin M. Ibanez · 2019 to 2026
$6.1M
Social epigenetics of Alzheimer's disease and related dementias in Latin American countriesR01AG082056 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Michael Jay Corley · 2024 to 2026
$3.6M
Circadian Disturbance and Dementia in Latin AmericaR01AG083799 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Kun Hu, Agustin M. Ibanez · 2023 to 2026
$3.0M
Alzheimer's Association SG-20-725707ANID/FONDAP 15150012ANID/FONDECYT RegularANID/PIA/ANILLOS ACT210096CONICET 1210176CONICET 1210195CONICET 1220995Fogarty International Center (FIC), National Institutes of Health, National Institutes of Ageing AG057234Fogarty International Center (FIC), National Institutes of Health, National Institutes of Ageing AG075775Fogarty International Center (FIC), National Institutes of Health, National Institutes of Ageing AG082056Fogarty International Center (FIC), National Institutes of Health, National Institutes of Ageing AG083799Fogarty International Center (FIC), National Institutes of Health, National Institutes of Ageing CARDS-NIH 75N95022C00031FONDEF ID20I10152Global Brain Health InstituteNational Institute for Health and Care Research (NIHR) Leeds Biomedical Research Centre NIHR203331NIA NIH HHS R01 AG057234NIA NIH HHS R01 AG075775NIA NIH HHS R01 AG082056NIA NIH HHS R01 AG083799NIDA NIH HHS 75N95022C00031Rainwater Charitable Foundation - The Bluefield Project to Cure FTDTakeda Pharmaceutical Company CW2680521UK Research and Innovation Biotechnology and Biological Sciences Research Council BB/X008428/1
6 · The paper itself

Abstract

The current lack of diversity in neuroimaging datasets limits the potential generalisability of research findings. This situation is also likely to have a downstream impact on our ability to translate fundamental research into effective interventions and treatments for the global population. We propose that electroencephalography (EEG) is viable for delivering truly inclusive and global neuroscience. Over the past two decades, advances in portability, affordability, and computational sophistication have created a tool that can readily reach underrepresented communities and scale across low-resource contexts-advantages that surpass those of other neuroimaging modalities. However, skepticism persists within the neuroscience community regarding the feasibility of realizing EEG's full potential for studying the brain on a global scale shortly. We highlight several challenges impeding progress, including the need to amalgamate large-scale, harmonized datasets to provide the statistical power and robust computational frameworks necessary for examining subtle differences between populations; the advancement of EEG technology to ensure high-quality data acquisition from all individuals-irrespective of hair type-and operable by nonspecialists; and the importance of engaging directly with communities to cocreate culturally sensitive and ethically appropriate research methodologies. By tackling these technical and social challenges and building on initiatives dedicated to inclusivity and collaboration, we can harness EEG's potential to deliver neuroscience genuinely representative of the global population.

Indexed as

BrainElectroencephalographyNeurosciencesHumansNeuroimagingcommunity engagementdata harmonizationelectroencephalography (EEG)global neuroimaginginclusivity

Identifiers

PMID40103341
PMCPMC11920675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.